Skip to main navigation
Skip to main content
Ky.
gov
An Official Website of the Commonwealth of Kentucky
alert toggle
Kentucky
Board of Pharmacy
Menu
LICENSURE GATEWAY PORTAL
Board Information
Overview
Board Members
Board Staff
Board Meetings
Board Committees
Facilities
Overview
Pharmacy Permits
Manufacturers
Wholesalers
Third Party Logistics Providers
Outsourcer Facilities
Legend Drug Repository Program
Resident Pharmacy Permits
Non-Resident Pharmacy Permits
Professionals
Overview
Pharmacist Information
Pharmacist Interns
Pharmacy Technicians
KY Professionals Recovery Network
Continuing Education
KASPER Information
Initial Pharmacist Licensure Information
Reciprocal Licensure Information
Foreign Pharmacist Graduate Information
Statutes and Regulations
Overview
Kentucky Pharmacy Lawbook
Board Authorized Protocols
Frequently Asked Questions
Additional Resources
Grievance Process
Inspector Regions
Data Rosters
Open Records
Opinions and Declaratory Rulings
PHARMACY
Toggle navigation
PHARMACY
Page Image
Board Authorized Protocols
Main Content
201 KAR 2:380: This administrative regulation establishes procedures for board authorized protocols by which pharmacists may initiate the dispensing of noncontrolled medications or other professional services.
Important Reminders:
The protocol may only be signed by a Kentucky licensed physician or Kentucky licensed advanced practice registered nurse practitioner. No other practitioner (e.g. Physician Assistant) will have the authority to sign a board authorized protocol;
Only pharmacists who are party to the protocol agreement are allowed to implement/utilize the protocol;
Pharmacists utilizing the protocol must be appropriately licensed and employed by or contracted with the permit holder;
The PIC is responsible for submitting the fully executed protocol to the Board of Pharmacy and for submitting notification of discontinuation of the protocol no later than 30 days after discontinuing the protocol;
The protocol must be sent to the Board of Pharmacy prior to implementation;
The Protocol Review Committee meets quarterly to evaluate new proposed protocols and review previously authorized protocols.
All fully executed board authorized protocols must be submitted to the Board via the Licensure Gateway Portal prior to being implemented .
Please note: immunization and naloxone protocols are not required for submission to the board.
Relative Content
Board Authorized Protocols
HIV Pre-Exposure Prophylaxis (PrEP) Protocol
SARS-CoV-2 Infection Protocol
Acute Influenza Infection Chemoprophylaxis Protocol
Self-Care Conditions Protocol Diabetes Testing and Injection Supplies
Self-Care Conditions Protocol Over-the-Counter Dietary Supplement
Self-Care Conditions Protocol Over-the-Counter Probiotics
Acute Influenza Infection Antiviral Therapy Protocol
Acute Group A Streptococcal Pharyngitis
Paxlovid Protocol
Alcohol Use Disorder Protocol utilizing Naltrexone-based Therapy
Colorectal Cancer [CRC] Screening Protocol
Travel Health Therapies Protocol
Self-Care Protocol Emergency Contraceptive
Nutritional Supplementation Protocol
Acute Uncomplicated Urinary Tract Infection Treatment Protocol
Anaphylaxis Treatment Protocol for Emergency Epinephrine Injection Devices
Protocol for Pharmacist Dispensing of Allergic Rhinitis Therapies
Self-Care Conditions Protocol Diabetes Testing Supplies
, Protocol expires December 31, 2025
Tobacco Cessation Protocol
Tuberculin Skin Testing One-Step Protocol
Tuberculin Skin Testing Two Step Protocol
Naltrexone-based Therapy for Opioid Use Disorder Protocol
Resource Documents
Additional Signature Page